The efficacy and safety of feverfew (Tanacetum parthenium L.): an update of a systematic review (Q30660353)

26 June 2017

1 reference

1 reference

title

The efficacy and safety of feverfew (Tanacetum parthenium L.): an update of a systematic review (English)

1 reference

26 June 2017

0 references

1 reference

Ernst E

1

1 reference

26 June 2017

Pittler MH

series ordinal

2

1 reference

26 June 2017

language of work or name

English

0 references

publication date

1 December 2000

1 reference

26 June 2017

published in

Public Health Nutrition

1 reference

26 June 2017

volume

3

1 reference

26 June 2017

issue

4A

1 reference

26 June 2017

page(s)

509-514

1 reference

Alternative therapy bias.

26 June 2017

cites work

1 reference

https://api.crossref.org/works/10.1017%2FS1368980000000598

7 January 2021

Publication bias in clinical research

1 reference

https://api.crossref.org/works/10.1017%2FS1368980000000598

7 January 2021

Chromosomal aberrations and sister chromatid exchanges in lymphocytes and urine mutagenicity of migraine patients: a comparison of chronic feverfew users and matched non-users

1 reference

https://api.crossref.org/works/10.1017%2FS1368980000000598

7 January 2021

The Essential Oil ofTanacetum parthenium (L.) Schultz-Bip.

1 reference

https://api.crossref.org/works/10.1017%2FS1368980000000598

7 January 2021

Assessing the quality of reports of randomized clinical trials: is blinding necessary?

1 reference

https://api.crossref.org/works/10.1017%2FS1368980000000598

7 January 2021

Compositae dermatitis in South Australia: contact dermatitis from Chrysanthemum parthenium

1 reference

https://api.crossref.org/works/10.1017%2FS1368980000000598

7 January 2021

Extracts of feverfew may inhibit platelet behaviour via neutralization of sulphydryl groups

1 reference

https://api.crossref.org/works/10.1017%2FS1368980000000598

7 January 2021

Prostaglandin synthetase inhibitors in feverfew

1 reference

https://api.crossref.org/works/10.1017%2FS1368980000000598

7 January 2021

Location bias in controlled clinical trials of complementary/alternative therapies.

1 reference

https://api.crossref.org/works/10.1017%2FS1368980000000598

7 January 2021

Nocturnal Melatonin Excretion is Decreased in Patients With Migraine Without Aura Attacks Associated With Menses

1 reference

https://api.crossref.org/works/10.1017%2FS1368980000000598

7 January 2021

Patient numbers needed in prophylactic migraine trials.

1 reference

https://api.crossref.org/works/10.1017%2FS1368980000000598

7 January 2021

Trends in alternative medicine use in the United States, 1990-1997: results of a follow-up national survey

1 reference

https://api.crossref.org/works/10.1017%2FS1368980000000598

7 January 2021

Herbal medicines in migraine prevention Randomized double-blind placebo-controlled crossover trial of a feverfew preparation

1 reference

https://api.crossref.org/works/10.1017%2FS1368980000000598

7 January 2021

How do the currently used prophylactic agents work in migraine?

1 reference

https://api.crossref.org/works/10.1017%2FS1368980000000598

7 January 2021

Pharmacological activity of feverfew (Tanacetum parthenium (L.) Schultz-Bip.): assessment by inhibition of human polymorphonuclear leukocyte chemiluminescence in-vitro

1 reference

https://api.crossref.org/works/10.1017%2FS1368980000000598

7 January 2021

Melatonin in feverfew and other medicinal plants

1 reference

https://api.crossref.org/works/10.1017%2FS1368980000000598

7 January 2021

10.1017/S1368980000000598

Identifiers

DOI

0 references

1 reference